Eisai and Nuvation Bio report taletrectinib MAA validated by European regulator

Novo Nordisk's Awiqli once-weekly basal insulin treatment approved by US FDA

Kodiak Sciences reports positive Phase 3 results for Zenkuda in diabetic retinopathy

Iterion Therapeutics reports first patient dosed in phase 1/2 trial of tegavivint in colorectal cancer

SciTech Development reports early-stage clinical data from Phase 1a trial of ST-001 nanoFenretinide at USCLC Annual Workshop 2026

Clarity Pharmaceuticals signs copper-64 manufacturing agreement with Theragenics

Merck to acquire Terns Pharmaceuticals for USD6.7bn

Maze Therapeutics reports positive Phase 2 data for MZE829 in patients with AMKD

Bio-Techne expands COMET spatial biology platform with new SPYRE Panels and Amplification Kits

CRISM Therapeutics advances Phase 2 glioblastoma trial with initial ChemoSeed batch manufactured

Myosin Therapeutics granted USD2m funding from Florida Department of Health

Clover Biopharmaceuticals reports positive US Phase I data for RSV re-vaccination in older adults

Hope Medicine reports first patient dosed in Phase III trial of HMI-115

Akeso's Phase II trials of AK146D1 and AK138D1 approved in China

Insilico Medicine and ASKA Pharmaceutical expand partnership on women's health targets